Jones Christy sold 1,998 shares of Beta Bionics, Inc. at $9.95 for −$19.9k on May 21, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed May 26, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$19,880.10Shares × reported price
Shares traded
1,998Common Stock
Price per share
$9.95Reported price. Read footnotes for ranges.
% of reported position traded
13.11%This security and ownership context
Holdings after
13,246Direct
Trade date
May 21, 2026Sell
Filed
May 26, 2026, 6:00 PM ET5-day reporting delay
Accession
0002048467-26-000003Code S · Transaction 385747
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 15,244 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 21, 2026Grant16,965$0.00$0Trade 385748
2 transaction rows in this filing. Joint filers share the same rows.

BBNX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BBNX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +4.7%1w ago −22%1d ago −14%
Returns since7d +9.1%30d +36%90d +68%180d1y

Footnotes in full

F1: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026. F2: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.